NewGenIvf (NIVF) Payables (2022 - 2025)

NewGenIvf has disclosed Payables across 4 years of filings, most recently posting $346444.0 for Q4 2025.

• In Q4 2025, Payables rose 38.46% year-over-year to $346444.0; the TTM figure through Dec 2025 stood at $346444.0 (up 38.46% YoY), while the FY2025 annual figure was $346444.0, up 38.46% from the prior year.
• Payables slipped to $346444.0 in Q4 2025, from $797.7 billion in the prior quarter.
• Over the last five years, Payables for NIVF reached as high as $797.7 billion in Q3 2025 and fell as low as $64077.0 in Q4 2022.
• The 4-year median for Payables is $298326.5 (2024), against an average of $133.0 billion.
• Annual changes were most pronounced in 2023 — Payables surged 169.4% — and 2025, when it jumped 38.46%.
• A 4-year view of Payables shows it stood at $64077.0 in 2022, then surged by 169.4% to $172626.0 in 2023, then surged by 44.94% to $250209.0 in 2024, then soared by 38.46% to $346444.0 in 2025.
• According to Business Quant data, Payables over the past three periods registered $346444.0, $797.7 billion, and $876253.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.